Wambolt & Associates, LLC Novartis Ag Transaction History
Wambolt & Associates, LLC
- $333 Million
- Q1 2024
A detailed history of Wambolt & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wambolt & Associates, LLC holds 28,225 shares of NVS stock, worth $3 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
28,225
Previous 24,800
13.81%
Holding current value
$3 Million
Previous $2.5 Million
9.03%
% of portfolio
0.82%
Previous 0.44%
Shares
22 transactions
Others Institutions Holding NVS
# of Institutions
1,343Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.32 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.32 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$773 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$641 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$630 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...